A group of researchers, including oncologists and data scientists, from the University of Florida and Indiana University hypothesized that GLP-1s hold promise in oncology due to their ability to lower glucose, adiposity, insulin resistance, and systemic inflammation factors associated with cancer progression, according to a July 2025 paper published in JAMA
If weekly injections have kept you from signing up for our semaglutide program, theres now another option
Journal of Adolescent Health, 49 (5), 525-531
Phase I trials have been completed for hematological tumors (NCT02071888) and leukemias (NCT02071927), although no clinical data is publicized
Data shows that 1.6 million adults in England, Wales, and Scotland used a GLP-1 medication for weight loss between 2024 and 2025
I have more energy and clothes that I had not when in a while are finally fitting